These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6304300)

  • 1. Displacement reactions employing heterologous tracer ligands in peptide receptor studies: a review.
    Pliska V
    J Recept Res; 1983; 3(1-2):227-38. PubMed ID: 6304300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide hormone receptors.
    Catt KJ; Dufau ML
    Annu Rev Physiol; 1977; 39():529-57. PubMed ID: 15500
    [No Abstract]   [Full Text] [Related]  

  • 3. Analytical determination of receptor-ligand dissociation constants of two populations of receptors from displacement curves.
    Almagor H; Levitzki A
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6482-6. PubMed ID: 2168549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites?
    Swillens S; Waelbroeck M; Champeil P
    Trends Pharmacol Sci; 1995 May; 16(5):151-5. PubMed ID: 7624969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA; Kusachi S; Thompson RD; Ukena D; Padgett W; Daly JW
    J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of receptor binding displacement curves by a nonhomologous ligand, on the basis of an equivalent competition principle.
    van Zoelen EJ
    Anal Biochem; 1992 Feb; 200(2):393-9. PubMed ID: 1321566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physico-chemical study of the heterogeneous population of opioid receptors].
    Kurochkin IN; Zaĭtsev SV; Belousov AS; Skliankina OA; Varfolomeev SD
    Biokhimiia; 1988 Jan; 53(1):41-53. PubMed ID: 2833940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of synthetic N- and C-terminal fragments of helodermin with rat liver VIP receptors.
    Robberecht P; Yanaihara N; Yanaihara C; De Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J
    Peptides; 1986; 7 Suppl 1():79-82. PubMed ID: 3018706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of opioid binding sites in the neural and intermediate lobe of the rat pituitary gland by quantitative receptor autoradiography.
    Boersma CJ; Pool CW; Van Heerikhuize JJ; Van Leeuwen FW
    J Neuroendocrinol; 1994 Feb; 6(1):47-56. PubMed ID: 8025568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone receptor-coupling factor-adenylate cyclase interaction: theoretical considerations.
    Blum JJ
    J Theor Biol; 1984 Dec; 111(3):589-608. PubMed ID: 6151613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo(3.2.1)octanes.
    Barlocco D; Fadda P; Fratta W
    Farmaco; 1993 Mar; 48(3):387-96. PubMed ID: 8391821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
    Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
    Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat kappa-opioid receptor.
    Soderstrom K; Choi H; Berman FW; Aldrich JV; Murray TF
    Eur J Pharmacol; 1997 Nov; 338(2):191-7. PubMed ID: 9456002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of receptor-ligand kinetic and equilibrium binding constants using surface plasmon resonance: application to the lck SH2 domain and phosphotyrosyl peptides.
    Morelock MM; Ingraham RH; Betageri R; Jakes S
    J Med Chem; 1995 Apr; 38(8):1309-18. PubMed ID: 7537332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
    Bhargava HN; Das S
    Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence displacement method for the determination of receptor-ligand binding constants.
    Kuzmic P; Moss ML; Kofron JL; Rich DH
    Anal Biochem; 1992 Aug; 205(1):65-9. PubMed ID: 1332537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opiate receptor and opoid peptides.
    Snyder SH; Simantov R
    J Neurochem; 1977 Jan; 28(1):13-20. PubMed ID: 188984
    [No Abstract]   [Full Text] [Related]  

  • 18. Secretin receptors on neuroblastoma cell membranes: characterization of 125I-labeled secretin binding and association with adenylate cyclase.
    Roth BL; Beinfeld MC; Howlett AC
    J Neurochem; 1984 Apr; 42(4):1145-52. PubMed ID: 6321661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma antidiuretic hormone levels and liver vasopressin receptors in the jerboa, Jaculus orientalis, and rat.
    Butlen D; Baddouri K; Rajerison RM; Guillon G; Cantau B; Jard S
    Gen Comp Endocrinol; 1984 May; 54(2):216-29. PubMed ID: 6329898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptor agonists: binding and adenylate cyclase stimulation in rat liver plasma membranes.
    Schütz W; Tuisl E; Kraupp O
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):34-9. PubMed ID: 6287298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.